Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2

被引:35
作者
Schwartz, JD [1 ]
Monea, S [1 ]
Marcus, SG [1 ]
Patel, S [1 ]
Eng, K [1 ]
Galloway, AC [1 ]
Mignatti, P [1 ]
Shamamian, P [1 ]
机构
[1] NYU, Sch Med, Dept Surg, S Arthur Localio Surg Res Lab, New York, NY 10016 USA
关键词
neutrophils; matrix metalloproteinases; MMP-2; proteolytic activation;
D O I
10.1006/jsre.1998.5294
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective. Polymorphonuclear leukocyte (PMN) infiltration and microvascular injury are hallmarks of the tissue remodeling associated with multiple organ failure. These processes require the concerted action of various proteolytic enzymes, including serine and matrix metalloproteinases (MMPs). Matrix metalloproteinase-a (MMP-2) plays an important role in the turnover of various ECM components, including type TV collagen, fibronectin, and gelatins. Like all MMPs, MMP-2 is secreted as an inactive zymogen (proMMP-2) and activated extracellularly by limited proteolytic cleavage. The physiologic mechanism(s) of proMMP-2 activation remains unclear. This study was designed to characterize the effect of PMNs on the activation of proMMP-2 produced by endothelial cells. Methods. PMNs and human umbilical vein endothelial cells (HUVECs) were grown either separately or together for 2-16 h. To evaluate the role of cell-cell contact, cocultures were also established in which the two cell types were separated by a semipermeable polycarbonate membrane. Alternatively, PMN-conditioned medium was added to HUVEC cultures with or without various proteinase inhibitors (aprotinin, 1,10-phenanthroline, Batimastat, E-64, eglin c peptide, or pepstatin A). After incubation, the culture supernatants were analyzed by gelatin zymography to characterize the gelatinases. 'Results. HUVECs produce MMP-2 in its inactive (72 kDa) form. PMNs produce high levels of MMP-9 (gelatinase B, 92 kDa) but no MMP-2. Coculture of PMNs with or addition of PMN-conditioned medium to HUVECs results in the production of active (62 kDa) MMP-2. ProMMP-2 activation by PMN-conditioned medium is not blocked by inhibitors of plasmin, cysteine-, acid-, or metalloproteinases. Conclusion. PMNs release a soluble factor that activates endothelial cell MMP-2 through a novel mechanism independent of cell-cell contact and not attributable to the activities of plasmin, cysteine-, acid-, or metalloproteinases. These findings may provide insight into the tissue remodeling that accompanies PMN-mediated microvascular injury. (C) 1998 Academic Press.
引用
收藏
页码:79 / 85
页数:7
相关论文
共 28 条
[1]   MATRIX METALLOPROTEINASE-2 IS AN INTERSTITIAL COLLAGENASE - INHIBITOR-FREE ENZYME CATALYZES THE CLEAVAGE OF COLLAGEN FIBRILS AND SOLUBLE NATIVE TYPE-I COLLAGEN GENERATING THE SPECIFIC 3/4-LENGTH AND 1/4-LENGTH FRAGMENTS [J].
AIMES, RT ;
QUIGLEY, JP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (11) :5872-5876
[2]   Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes [J].
Atkinson, SJ ;
Crabbe, T ;
Cowell, S ;
Ward, RV ;
Butler, MJ ;
Sato, H ;
Seiki, M ;
Reynolds, JJ ;
Murphy, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (51) :30479-30485
[3]   THE THROMBIN RECEPTOR EXTRACELLULAR DOMAIN CONTAINS SITES CRUCIAL FOR PEPTIDE LIGAND INDUCED ACTIVATION [J].
BAHOU, WF ;
COLLER, BS ;
POTTER, CL ;
NORTON, KJ ;
KUTOK, JL ;
GOLIGORSKY, MS .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) :1405-1413
[4]   MULTIPLE ORGAN FAILURE SYNDROME IN THE 1990S - SYSTEMIC INFLAMMATORY RESPONSE AND ORGAN DYSFUNCTION [J].
BEAL, AL ;
CERRA, FB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (03) :226-233
[5]   POSTINJURY NEUTROPHIL PRIMING AND ACTIVATION - AN EARLY VULNERABLE WINDOW [J].
BOTHA, AJ ;
MOORE, FA ;
MOORE, EE ;
KIM, FJ ;
BANERJEE, A ;
PETERSON, VM .
SURGERY, 1995, 118 (02) :358-365
[6]   SEPARATION OF LEUKOCYTES - IMPROVED CELL PURITY BY FINE ADJUSTMENTS OF GRADIENT MEDIUM DENSITY AND OSMOLALITY [J].
BOYUM, A ;
LOVHAUG, D ;
TRESLAND, L ;
NORDLIE, EM .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1991, 34 (06) :697-712
[7]  
COLLIER IE, 1988, J BIOL CHEM, V263, P6579
[8]  
GAY JC, 1990, J LIPID MEDIATOR, V2, pS161
[9]  
Gilles C, 1996, INT J CANCER, V65, P209
[10]  
Goldberg G I, 1992, Matrix Suppl, V1, P25